HIGHLIGHTS
- who: Daehun Kwag from the (UNIVERSITY) have published the research work: Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis, in the Journal: (JOURNAL) of 16/09/2022
- what: This study compared DEC + VEN with DEC monotherapy in a propensitymatched cohort including older adults with newly diagnosed AML to clarify effects of adding VEN to DEC therapy. This study has inherent limitations due to its retrospective design.
- how: The authors calculated the propensity score using a logistic regression model that included age performance status (determined by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.